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Complex*
The kinetic parameters of the conversion of bovine
prothrombin into thrombin by activated bovine blood
clotting factor X (X") have been determined in the
absence and presence of Caz*, activated bovine factor
V (V"), and phospholipid (dioleoylphosphatidylcholine/
dioleoylphosphatidylserine, 1:1; mol/mol). In the ab-
sence of accessory components, the K- for prothrombin
is 131 trrru, which is well above its concentration in
bovine plasma of about 1.5 p,u. The Y-o of thrombin
formation is 0.61 mol min-l mol of X"-r under these
conditions. In the presence of 7.5 pu phospholipid, the
K- drops to 0.058 pnr and the I/-* slightly increases to
2.25 nol min-l mol of X". For the complete prothrom-
binase complex (X", V., Ca2*, and 7.5 trru phospholipid)'
a K^ fot prothrombin of 0.21 ;nn and a y-* of 1919 mol
min-l mol of X"-1 is found. The V-* of thrombin for-
mation slightly increases when more phospholipid is
present in our experiments and there is a considerable
increase of the K^ for prothrombin at higher phospho-
lipid concentrations. Preliminary calculations show
that the prothrombin density at the phospholipid sur-
face at the K^ is independent of the phospholipid con-
centration. This indicates that the K^ measured in the
presence of phospholipid has to be regarded as an
apparent K^ and. the local prothrombin concentration
determines the kinetics of activation.
Prothrombin activation by prothrombinase com-
plexes of different compositions was followed by gel
electrophoresis in the presence of sodium dodecyl sul-
fate. Both in the absence and presence of phospholipid
but without factor V., prethrombin 2 is the main prod-
uct formed during the initial stages of steady state
prothrombin activation. In the presence of factor V.,
thrombin is the main end product and minute amounts
of prethrombin 2 are formed. This shift in the reaction
pathway of prothrombin activation eaused by factor Vu
will contribute to the observed increase of the 7-*
measured in the presence of factor V,.
One of the key reactions in blood coagulation and hemosta-
sis is the formation of thrombin by limited proteolysis of its
zynogen, prothrombin.r Several proteolytic enzymes can
bring about this reaction, but under physiological conditions
the serine protease factor X" is the activating enzyme. In the
* This investigation was partially supported by the Netherlands
Organization for the Advancement of Pure Scientific Research
(Z.W.O.). Part of the chromogenic substrates used in our laboratory
were kindly donated by AB Kabi Diagnostica. The costs of publication
of this article were defrayed in part by the payment of page charges.
This article must therefore be hereby marked "aduertisement" in
accordance with 18 U.S.C. Section 1734 solely to indicate this fact.I The nomenclature of the blood coagulation factors used is that
recommended by the Task Force on Nomenclature of Blood Clotting
Zymogens and Zymogen Intermediates.
last 25 years many papers have appeared in the literature
describing the detection and isolation of partial proteolysis
products of prothrombin (see Ref. 1). They finally resulted in
a series of papers by the group of Jackson et al. (2-7\ which
completed the description ofthe sites ofpeptide-bond splitting
and order of bond cleavage during prothrombin activation.
Papahadjopoulos and Hanahan (8) as well as several other
authors (see Ref. 1) have shown that additional components
are essential for prothrombin activation during in uitroblood
coagulation. It is now generally accepted that Ca2*, a phos-
pholipid surface, and factor V, are required for prothrombin
activation under physiological conditions. It has been shown
that the above mentioned clotting factors have to be absorbed
on the phospholipid bilayer surface in order to acquire effi-
cient interaction. Both prothrombin and factor X" bind to the
phospholipid surface via calcium bridges between y-carboxy-
glutamic acids present in these proteins and polar head groups
of the phospholipid molecules (9, 10), while hydrophobic
interactions play an important role in the binding of factor V.
(11). For a recent review about phospholipid involvement in
blood coagulation, see Ref. 12.
Not much is known, however, about the mechanism respon-
sible for the enhancement of the rate of prothrombin activa-
tion by factor V. and phospholipids. Esmon and Jackson (5)
did not find evidence for a change of sites and orders ofbond
cleavage when the prothrombin molecule is activated by
different combinations of the components of the prothrombin-
ase complex. The enhancement of the rate of thrombin for-
mation when phospholipid or factor V,, or both, are added to
a mixture of prothrombin, factor X', and CaClz as such (7;
13), does not allow conclusions about the way they are in-
volved in the enz5rmatic mechanism of prothrombin activa-
tion, since these experiments were carried out at single con-
centrations of the components of the prothrombinase com-
plex.
The purpose of the experiments described in this paper was
to assess the kinetic parameters (K- for prothrombin and 7-,"
of thrombin formation) for different prothrombin activating
mixtures (1.e. factor X' either in the absence or presence of
Ca2*, factor V., and/or phospholipid). This enables a precise
quantitation of the observed rate enhancements and allows a
first attempt to explain the role of the accessory components
in the mechanism of prothrombin activation.
Silverberg et al. (14) have reported an example of the effect
of an accessory component on the kinetics of a proteinase-
catalyzed activation of a clotting factor. They studied the
effect of tissue factor on the activation of factor X by factor
VII.. Tissue factor, a preparation which contains both phos-
pholipids and protein components decreased the K^ for factor
X about 10-fold and increased the K"ut 3000-fold. Our kinetic
approach allows a separate assessment of the effects of phos-
pholipid and the protein accessory component (factor V.) of
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the prothrombinase complex on the kinetic parameters of
prothrombin activation. The data presented in this paper
likely have implications for the role of phospholipid and faclor
VIII in the factor X-activating complex (factor IX., factor
VIII, Ca2*, and phospholipid) of the intrinsic pathway of blood
coagulation.
EXPERIMENTAL PROCEDURES
Materials-S 22382 and S 2222 werc purchased from AB Kabi
Diagnostica, Stockholm, Sweden.p-NPGB was from Nutritional Bio-
chemicals. Russell's viper venom, soybean trypsin inhibitor, and
ovalbumin were obtained from Sigma. DEAE-Sephadex A-bO, eAE-(quarternaryammoniumethyl) Sephadex A-50, Sp (sulfopropyl)
Sephadex C-50, Sephadex G-100, Sepharose 48 and 68, and-CNBr-
activated Sepharose 48 were obtained from pharmacia. eAE-CelIu-
Iose was a product of Schleicher and Schuell. p-Aminobenzamidine
obtained from Merck was coupled to Sepharose 48 according to the
procedure described by Di Scipio et al. (lS). STI was coupled to
CNBr-activated Sepharose 48 following the method of Cuatrecasas(16). AI reagents used were of the highest grade commercially avail-
able.
Proteins-Bovine prothrombin was prepared according to the
method of Owen et al. (2). Before storage at -80.C the prothrombin
preparations were passed through a column (0.9 X 20 cm) of Sp-
Sephadex and STl-Sepharose 48 to reduce the small amounts of
thrombin and factor X" which might be present in these preparations.
No thrombin and factor X. could be detected in our final prolhrombin
preparations using an assay with the chromogenic substrates S 22Bg
and S 2222. Prothrombin concentrations were calculated from the
.E2s using EL76 = 75.5 (2) and 72,UJ0 for the molecular weight of
prothrombin (2). Bovine factors X1 and Xz were purified as described
by Fujikawa et al. (171. Bovine factor X" was prepared from factor X2
using RW-X according to the method of Fujikawa et al. (18).Factor
X, concentrations were calculated after active site titration accordinq
to Smith (19).
Prothrombin, factor X1 and factor X2 preparations were homoge-
neous and pure as determined by gel electrophoretic analysis in the
presence of sodium dodecyl sulfate. The specific activities attained
were equal to those reported in Ref. 2 (for prothrombin) and Ref. lZ(for factor Xr and Xz).
RVV-X was purified from the crude venom bv the method of
Schiffman e/ a/. (20). Factor V was purified according to the procedure
of Smith and Hanahan (21) with minor modifications. The final
preparation had a specific activity of 40 U/mg assuming 1 unit of
factor V to be present per ml of normal bovine plasma. Factor V (0.4
mClrnl) was activated at 37"C for 1b min in 200 mu Tris-HCl, 50 mu
NH4CI, 1070 glycerol (pH 7.5) with thrombin (1.31 pglml). After this
time interval the specific activity had risen to aboul 320 U/mg and
did not increase upon Ionger incubation. Factor V, was separated
from thrombin on a benzamidine-sepharose 48 column, which to our
surprise also bound some of the factor V". The bound factor V, coulrl
be eluted with 20 mM Tris, 200 mnt NaCl (pH 7.b).
Thrombin was purified as a prothrombin activation product. pro_
thrombin (11.5 ml; 4.0 mglml) was activated with factor X" (2b p.g/
ml) in a solution containing 20 mu Tris, 100 mm NaCl, 20 -r,,r CaCL(pH 7.5) at 37"C. After 20 min 3 ml of STl-sepharose slurry was
added to bind factor X". Ten minutes later this mixture was applied
to QAE-Sephadex A-50 column (1.5 x B0 cm), and the prothrombin
activation products were eluted with a linear gradient (2 X f50 rnl) of
0.1 ru to 0.6 ru NaCl in 20 mu Tris at pH 7.5. The thrombin-containing
fractions were applied to a benzamidine-agarose column (l.b x fb
cm). Thrombin was eluted with a linear gradient (2 x 100 ml) of 0 to
0.3 u benzamidine in 0.1 ru NaCl, 20 mu Tris at pH 7.b (22).
Benzamidine was removed by passing the thrombin-containing frac-
tions through a Sephadex G-25 column (0.9 x 15 cm) followed bv
extensive dialysis against the same buffer without benzamidine at
5'C. The thrombin concentration was determined by active site
titration withp-NPGB according to Chase and Shaw (28).
2 The abbreviations used are: S 2288, H-o-phenylalanyl-r,-pipeco-
lyl-r-arginine-p-nitroanilide dihydrochloride; S 222i, N -benzovl_i-i"o_
leucyl-r,-glutamyl-glycyl-r,-arginine-p-nitroanilide hydrochtoria.; p-
NPGB,, p-nitrophenyl-p'-guanidinobenzoate hydrochloride; RW_k,
purified factor X activator from Russell's viper venom; STI, soybean
trypsin inhibitor.
Phospholipids and Phospholipid Vesicle preparations_1,2_Di_ i
oleoyl-sz-glycero-3-phosphocholine (18:1"r,218:1"r.-phosphatidylcho_ 
,,
line) was prepared by reacylating the cadmium chloiide adduciof sz-
glycero-3-phosphocholine with the appropriate fatty acyl chloride
according the method of Bear and Buchnea (2a). i,2_Dioleoyl-sn_
glycero-3-phosphoserine (18:1.r/18:1.i"-phosphatidylserine) was pre_
pared from the respective phosphatidylcholine by enzymatic synthesis
aS- described by Comfurius and Zwaal (2b). Singl bilayei vesicle
solutions were prepared according to the method descriLed by De
l!rytl{ 
"l 
al. (261 by sonication for 10 min in 20 mna Tris, tOd mnr
NaCl buffer at pH 7.5 at OoC (above the phase transition of the lipids
used). Sonication was performed using a MSE Mark II 150-watt
ultrasonic disintegrator set at 10 p peak to peak amplitude. After
sonication no pH adjustment was needed. phospholipid concentra_
ti^ons were determined by phosphate analysis aciording the method
ofBiittcher et al. (27). The vesicle preparations described above were
used throughout our experiments and were chosen because thev
exhibit excellent clot-promoting activity (2g).
Measurernent of Rates of Thrombin Formation-Factor X" either
alone or in the presence ofphospholipids, CaOlz, and/or factor Vu was
incubated for 3 to 5 min at 37.C in a buffer containing 20 mu Tris,
100 mu NaCl, and 0.5 mglml of ovalbumin at pH 2.5. prothrombin
was added and after different time intervals samples were taken and
added to a cuvette (thermostated at B7"C), containing B0 pg of STI
and 0.47 pmol of S 2238 in such an amount of the above buifer that
the final volume became 2 m]. The amount of STI is sufficient to
inhibit further conversion of prothrombin and to inhibit the low
amidase activity of factor X. with S 2238. It does, however, not affect
the rate of conversion of S 2238 by thrombin. From the absorbance
change at 405 nm, recorded on a Gilford spectrophotometer, the
amount of thrombin is calculated from a calibration cuwe made with
known amounts of thrombin. The calibration curve was determined
under the assay conditions described above. The rate of thrombin
formation in the incubation mixture is calculated from the amounts
of thrombin present in the samples taken after different time intervals.
Pure prethrombin I and prethrombin 2 have negligible amidase
activity toward S 2238 and, therefore, do not contribute to the
absorbance changes measured. Ovalbumin (0.b mg,zml) was included
in all protein solutions and incubations in order to prevent inactiva_
tion of the proteins.
For the construction ofLineweaver-Burk plots the rate ofthrombin
formation was averaged from three independent determinations. K_,
V-*, and the relevant standard errors were determined using the
weighted and nonlinear regression method described bv Wilkinson(29). Lines were drawn accordingly.
Gel Electrophoretic Analysis of prothrombin Actiuation_Gel
electrophoresis in the presence of sodium dodecyl sulfate was carried
out as desc-ribed by Laemmli (80) on gels containing l07o acrylamide,
O^.277o N,If-methylenebisacrylamide, and 0.17o soJium dodecyl sul_
fate. A-liquots (10 to 50/jl) of the incubation mixtures were added to
50 p"l of 2Vo sodium dodecyl sulfate, 50 mvr EDTA (pH 7.b) and kept
for 4 min in a boiling water bath. Five per cent mercaptoethanol was
present in disulfide-reduced gel samples.
RESULTS
Introductory Experiments to Determine the Conditions for
the Measurements of the Kinetic Parameters-To allow a
kinetic approach it is necessary to confirm that the rate of
thrombin formation is constant in time and proportional to
the amount of factor X. present for all different compositions
of the prothrombin-activating mixtures used. That this is the
case is shown in Fig. 1 where are plotted the amounts of
thrombin formed at different time intervals after starting the
reaction with varying known amounts of factor X,. Also when
phospholipid or factor V., or both, are present the rate of
thrombin formation is constant for a long period (measured
up to 20 min) and is proportional to the amount of factor Xu
over the entte range of factor X" concentrations used in the
further experiments (data not shown). The latter result indi-
cates that either a constant fraction of factor X, or all factor
X" added is bound to the phospholipid vesicles. Since the
maximal rate of thrombin formation increases only 4-fold
when the phospholipid concentration is increased from 2.6
pu to 240 ptr,t (Fig. 11, to be discussed below) we conclude that
at the low phospholipid concentrations 2SVo of the added
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formation in the presence of phospholipids (Fig. 6). In this
case no inhibitory effect of factor Vu is found, so the rates of
thrombin formation in the presence of phospholipid and sat-
urating amounts of factor V" can be regarded as true optimal
rates of prothrombin activation. In the presence of a l0-fold
higher phospholipid concentration the amount of factor V.
needed to obtain half-saturation is increased about 5 times.
and the optimal rate attained is about tSVo lower, which is
caused by a difference in the K*for prothrombin at high and
low phospholipid concentrations (see below).
Determination of the Kinetic Constants of Prothrombin
Conuersion uith Different Prothrombin Actiuation Mix-
tures-Rates of thrombin formation were measured at varying
prothrombin concentrations with different activation mix-
tures. When Ca'* or factor Vu, or both, are present, the data
l c " " l  ( m M )
Frc. 2. The Ca2* dependence of thrombin formation in the
absence and presence of factor V.. H, prothrombin (30
pru) was incubated at 37"C with factor X" (9.1 x 10-5 pmol,uml) in 1
ml of a buffer containing 20 mtu Tris-HCl, 100 mtvr NaCl, 0.5 mglml
of ovalbumin (pH 7.5), and varying amounts of CaClz. The rate of
thrombin formation was calculated from the amounts of thrombin
present after 5 and 10 min of incubation. A-A, prothrombin (1.12
pu) was incubated with factor X, (7.75 x 10-7 pmol/ml) and factor V,
(3.6 units/ml). Further experimental conditions as described above.
t o  2 0  3 0  4 0  5 0
I c a " ]  ( m M ]
Frc. 3. The Ca2* dependence of the rate of thrombin forma-
tion in the presence of phospholipid. Factor X, (3.1 x 10 6 pmol/
ml) was incubated at 37oC in 4 ml of a mixture containing 20 mu
Tris-HCl, 100 mu NaCl, ovalbumin (0.5 mglml), 7.5 pwI phospholipid
(A- ) or 75 pu phospholipid (H), and varying amounts of
CaClz at pH 7.5. After 3 min the reaction was started by adding 40
pl of prothrombin, resulting in a final concentration of 0.25 ptu. From
the amounts of thrombin present after 5 and 10 min the rate of
thrombin formation was calculated. The phospholipid vesicles were
prepared as described under "Experimental Procedures."
2 0  3 0
t i m e  ( m i  n  )
Frc. 1. fime course of thrombin formation with different
amounts of factor X.. Prothrombin (30 pu) was incubated with
varying amounts of factor X, in 1 ml of a buffer containing 20 mrvr
Tris-HCl, 100 mrr NaCl, 20 mM CaCl2, and 0.5 mglml of ovalbumin
(pH 7.5) at 37'C. After the time intervals indicated a sample was
taken and assayed for the amount of thrombin as described under
"Experimental Procedures." The amounts of factor Xu present were:
H, 9.1 x 10-5 pmol/ml;  -4, 18.2 x 10-5 pmol/rnl; and
H,45.6 x 10 spmol/ml.
factor Xu is bound to the phospholipid vesicles, while at the
higher phospholipid concentrations almost all factor X" added
is bound. The linearity of thrombin formation with time was
preserved for all prothrombin concentrations used through-
out.
It is well known that the rate of thrombin formation is
influenced by the presence of factor V" and Ca'* 17,13). In
order to compare rates in the presence or absence of the
accessory compounds it is necessary that the experiments be
carried out under optimal conditions with respect to the
amounts of these components. This was accomplished by
measuring thrombin formation at different factor V. and Ca2*
concentrations at constant amounts of factor X. and pro-
thrombin. Fig. 2 shows the Ca2* titration of thrombin forma-
tion when factor X, is converting prothrombin in solution in
the presence and absence of factor Vu. The shapes of the
titration curves and the optimal Ca2* concentrations are in-
dependent of prothrombin, factor Xu, and factor V. in the
concentration range used in our further experiments (not
shown). The significant inhibition at Ca2* concentrations
above 4 mM observed in the presence of factor V" remains as
yet unexplained. Similar Ca2* titrations have been carried out
for the prothrombinase complex consisting of phospholipids
and factor X. either in the absence or presence of factor V..
Fig. 3 shows the Ca2* dependence of the rate of thrombin
formation at two different phospholipid concentrations (7.5
and 75 ptvt) in the absence of factor V.. The same experiment
carried out in the presence of factor V" is shown in Fig. 4. It
is interesting to note that in the presence of factor Vu and
phospholipid the Ca2* titration curves are sigmoidal.
The dependence of the thrombin formation rate on the
amount of factor V^ present was measured at the optimal Ca2*
concentrations determined in the above mentioned experi-
ments. When factor X, converts prothrombin in solution in
the presence of 3 mu CaClz, large amounts of factor V" have
to be added in order to obtain the optimal rate of thrombin
formation (Fig. 5). The true maximal rate cannot be obtained
experimentally, however, since thrombin formation is in-
hibited at high factor V" concentrations. Much lower amounts
of factor V, are required to obtain an optimal rate of thrombin
4 01 0
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o
l c a - - l  ( m M  )
Frc. 4. The Ca2* dependence of the rate of thrombin forma-
tion in the presence of phospholipid and factor V". Factor X,
(3.1 x 10-'v pmol/ml) was incubated at 37oC in 4 ml of a mixture
containing 20 mru Tris-HCI, 100 mu NaCl, ovalbumin (0.5 mglml),
0.95 unit of factor V., 7.5 ptu phospholipid ( -A) or 75 pru phos-
pholipid (H), and varying amounts of CaClz at pH 7.5. After 3
min the reaction was started by adding 40 pl of prothrombin giving a
final concentration of 3 pM. For further experimental details see Fig.
D .
1 0  2 0
[ v " ]  ( u n i t s / m l )
Frc. 5. The faetor V" dependence of the rate of thrornbin
formation in solution. Factor X. (7.75 x l0-7 pmol/ml) was incu-
bated at 37"C in 1 ml of a mixture containing 20 mu Tris-HCI, 100
mM NaCl, ovalbumin (0.5 mglml), 3 mu CaCIz, and varying amounts
of factor V, at pH 7.5. After 5 min the reaction was started by addition
of 10 prl of prothrombin to give a final concentration of 1.12 pu. From
the amounts of thrombin present after 5 and 10 min of reaction time
the rate of thrombin formation was calculated.
from Figs. 2 to 6 have been used to select concentrations that
give an optimal rate of thrombin formation. In order to make
a direct comparison of the different Lineweaver-Burk plots
possible, rates of thrombin formation were expressed as moles
of thrombin formed per min per mol of factor X* present.
From the kinetic data the K- for prothrombin (in pru) and the
V-u* of thrombin formation (in moles of thrombin per min per
mol of X,) were determined. Fig. 7 shows the Lineweaver-
Burk plot of factor Xu conversion of prothrombin into throm-
bin in the absence of accessory components. From this plot a
K* of l3l pu and a V-,* of 0.61 mol min-1 mol X.-1 can be
calculated. When the same experiment is carried out in the
presence of 20 mrvr Ca2* there is a small decrease of the K*
while the 1/-.* is not affected. With a prothrombin activation
mixture consisting of factor X", Ca2*, and factor Y ^ , a K* of 34
pu is found (Fig. 8). In the presence of factor V. the maximal
rate of thrombin formation is increased about 600-fold to a
value of 373 mol min-r mol X.-1. Lineweaver-Burk plots of
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thrombin formation in the presence of phospholipid are shown
in Fig. 9 and 10. With a prothrombin activation mixture
consisting of factor X,, phospholipid (7 .5 ptr), and Ca2*, a V*.*
of 2.25 mol of thrombin min-1 mol X.-1 and a K^ of 0.058 pu
are found (Fig. 9). Increasing the phospholipid concentration
slightly increases the V*,,, and a much higher K- value is
measured. Compared with the kinetic parameterc measured
under the same conditions, but in the absence of phospholip-
ids, the considerable decrease of K- values is most striking.
Fig. 10 shows the Lineweaver-Burk plot of the complete
prothrombinase complex (factor X^, phospholipid, Ca2*, and
factor Vu). As expected this prothrombin activation mixture
yields kinetic constants which greatly favor thrombin forma-
tion. A low K- value for prothrombin, which is again depend-
ent on the phospholipid concentration, and a high V-", of
t " "J  (  ro2  un i ts /ml  )
FIc. 6. The effect of factor V" on the rate of thrombin for-
mation in the presence of phospholipid. Factor X" (2.3 x 10 'g
u.mol/ml) was incubated at 37"C in 4 ml of a mixture containing 20
mrr,r Tris-HCl, 100 mu NaCI, ovalbumin (0.5 mglml), 7.5 trru phospho-
lipid (H) or 75 pu phospholipid (A-A), 5 mv CaCl:, and
varying amounts of factor V, at pH 7.5. After 3 min the reaction was
started by adding 60 pl of prothrombin resulting in a final concentra-
tion of 0.95 pu. From the amounts of thrombin present after 4 and 8
min of reaction time, the rate of thrombin formation was calculated.
o  . o 5 0  . ' l o o  . 1 5 0
1 /  [ p ro th rom b in ]  (  / ! .M  )
Frc. 7. Lineweaver-Burk plot of factor X" converting pro-
thrombin into thrombin in the absence and presence of CaClz.
Thrombin formation at varying concentrations of prothrombin was
measured at 37"C in 1 ml of a reaction mixture containing 20 mlr
Tris-HCl, 100 mrvr NaCl, ovalbumin (0.5 mg,zml), factor X. (9.1 x 10-5
pmol/ml) at pH 7.5 without CaClr (H) and in the presence of 20
mrvr CaClz (A-A). The reaction was started by addition of factor
X". After 7r,4 and 15 min samples were taken and assayed for thrombin
as described under "Experimental Procedures." From the amounts of
thrombin found the rate of thrombin formation was calculated. The
kinetic constants calculated are summarized in Table I.
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1919 mol of thrombin min-1 mol X"-r at 7.5 trru phospholipid
can be calculated from the experimental data. Table I sum-
marizes the kinetic constants for thrombin formation with
different activation mixtures calculated from the data pre-
sented in Figs. 7 to 10.
The dependence of the kinetic parameters on the amount
of phospholipid present is studied in more detail for the
proihrombin-activating complex consisting of factor X., phos-
pfroUpia, and Ca'* (Table II). The gradual increase of the K-
Blood Coagulation
. 2  . 4
1 /  [ p r o t h r o m  b i n ] ( r . M  )
1 /  [ P r o t h r o m  b i n ]  (  / ^ t d ' )
Frc. 10. Lineweaver-Burk plot of factor X" converting pro-
thrombin into thrombin in the presence of phospholipid and
factor V". The experimental details are described in the legend of
Fig. 9 except the amount of factor X. was 7.75 x 10-to pmol/ml, and
0.9 U/ml o? factor V" was present. The CaClz concentrations were 7'5
mnr and 5.0 mu at, respectively, 7.5 pn'r phospholipid (A-A) and 75
pru phospholipid (H).
Tlsr,r I
Kinetic constants of thrombin formation with uarious prothrombin'
actiuating mixtures
Prothrombin-activat ing mixture
K- for pro-
thrombin v-""Frc. 8. Lineweaver-Burk plot of factor X" converting pro-
thrombin into thrombin in the presence of factor V" and CaClz'
Thrombin formation at varying prothrombin concentrations was
measured at 37oC in 1 ml of a reaction mixture containing 20 mu
Tris-HCI, 100 mu NaCl, ovalbumin (0'5 mglml), 3 mu CaCIz, factor
X" (7.75 x 10 ? pmol/ml), and factor V" (3.5 U/ml) at pH 7'5' The.
reaction was started by addition of prothrombin after 5 min of
preincubation. Further experimental details are as in Fig' 7' The
kinetic constants found ate summarized in Table I'
1 /  [ p r o t h r o m  b i n ]  t  2 n l )
Frc. 9. Lineweaver-Burk plot of factor X" converting pro-
thrombin into thrombin in the presence of phospholipid.
Thrombin formation at varying prothrombin concentrations was
measured at 3?'C in 4 ml of a reaction volume containing 20 mu Tris-
HCl. 100 mu NaCl, ovalbumin (0.5 mglml), factor X' (3.87 x 10-'
pmol/ml), 2.6 prvl phospholipid and 8rmr CaCIz (A-A), 7.5 ptvt
phospholipid and 15 mnr CaCIz (H) or 75 prvr phospholipid and
ZS -r.r CuCt, (H) at pH 7.5. The reaction was started after 3-
min preincubation by the addition of prothrombin. At 4 and 8 min
after prothrombin addition samples were taken from the reaction
mixtuie and assayed for thrombin in order to calculate the rate of
thrombin formation. The kinetic constants calculated are summarized
in Table I.
Factor X.
Factor X,, CaCI:
Factor X", CaClz, factor V'
Factor X", CaCb, PhospholiPid (2.6
rM)
Factor X,, CaCl2, phospholipid (7.5
uM)
Factor X,, CaCl2, PhosPholiPid (75
uu)
Factor X., CaClz, PhospholiPid (7.5
pm), factor V.
Factor X,, CaClz, PhospholiPid (75
pM ! S.E.
tsl !.24
8 4 1 1 1
3 4 - f 5
0.032 ! 0.003
0.058 ! 0.005
0.35 r 0.03
0.21 i 0.02
1.7 i  0.6
m o l  1 1 "  m l n
nol X.-1 t S.E.
0.61 t 0.08
0.68 + 0.06
373 ! 30
1.06 + 0.05
2.25 t O.05
3.9 -F 0.1
1919 r 63
2748 ! 580
prvr), factor V.
for prothrombin with increasing phospholipid concentrations
is obvious. The increase of the V-.* of the thrombin formation
at higher amounts of phospholipid is much less pronounced'
Thisls hkely due to the fact that the V-'" is determined by
the amount of factor X" actually bound to the phospholipid at
the different phospholipid concentrations. The kinetic pararn-
eters of free lactoi X" (Table I) are such that any nonbound
factor X. has no detectable contribution to thrombin forma-
tion in the presence of phospholipid. Thus variation of y-"*
with the phospholipid concentration is determined by the
binding isotherm of factor X. to varying amounts of phospho-
lipid. Extrapolation of a double reciprocal plot (l/V^".uersus
fTtpirosptrolipidl at constant factor X. to infinite phospholipid
concent.ation yietas tne V-." for the case that all factor X' is
bound (Fig. 1t. The V-"* calculated from this plot is 4 mol
min-t moiX.-1, which shows that even at the lowest phos-
pholipid concentration used in our experiments about 25Vo of
in" uaa"a factor Xu is bound to the phospholipid vesicles'
Time Course of Prothrombin Actiuation by Different Pro-
thrombin Actiuation Mixtures Visualized by Sodium Dodecyl
Sulfate Gel Electrophoresis-The experiments of the group
of iackson (2-7) have shown that different partial prothrom-
bin activation products accumulate during activation of pro-
thrombin with different activation mixtures' It can be argued
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Phospholipid CaCfz"
Tanlr II
Depend,ence of K^ and Vno, otl the phospholipid concentration
Prothrombin was activated by factor X, in the presence of Ca2*
and phosp_holipid. Reactions were carried out in a mixture containing4.6 
-x 10-7 pmol of X,/ml, 100 mrvr NaCl, 2b mn Tris, 0.8 mg o?ovalbumin,uml at B7"C and. pl{ ?.b. Amounts of phospirolipid "anJ
cacl2 present are indicated in the table. Furthei 
""i"ti"iu"t"i a"trir.are described in the legend to Fig. 9 and under ,,dxferimental pro_
cedures."
it is possible to follow prothrombin activation by differentprothrombin-activating mixtures using sodium dodecyl sulfategel electrophoresis (Fig. 12).
Prothrombin and its activation products are identified in
the figures. The relative migration distances and the sequence
of prothrombin and activation produbts on the gel are con_
sistent with earlier published gel data (2-6). In the absence offactor V. (with or without phospholipid) prethrombin 2 is the
main end product during the initial phase of prothrombin
activation (Fig. 12, A and C). At a later stage of the activationprocess sufficient thrombin is formed to be detectable on thegels. With factor Vu in the absence of phospholipid, thrombin
is generated in excess of prethrombin i (fig. 12,B), whereas in
the presence of phospholipid and factor Vl formation of pre_
thrombin 2 cannot be detected (FiS. LzD). These data point
out that in the presence of factor V" a shift in the pathway ofprothrombin activation occurs (see under .,Discussion',). For_
mation of prethrombin 1 during prothrombin activation will
take place as a result of thrombin-catalyzed, proteolysis ofprotbrombin. Indeed prethrombin 1 is formed during the time
course ofprothrombin activation. In particular, it is found in
those experiments where considerable amounts of thrombin
are formed.
DISCUSSION
The studies of Esmon et at. (Z) and Jobin and Esnouf (13)
have shown that both phospholipid and factor V. irr.."a"" tt 
"rate of_conversion of prothrombin to thrombin by factor X..
Since their experiments were carried out at a single concen_
tration of prothrombin, factor X., factor Vu, and ph-ospholipid,
no insight in the mechanistic function of factor V" and pt os_pholipid in the prothrombinase complex could be obtained.
Several explanations can be proposed for the rate enhance_
ments observed in the presence ofthe accessory components
of the prothrombinase complex (cf, Ref. I) e.g.: L a change in
the_reaction pathway of prothrombin activatiin; 2. an increase
ofthe proteolytic capacity offactor X, upon interaction with
phospholipid, factor V,, andlor Ca2*; J. a conformational
change of prothrombin upon binding to phospholipid, factor
V., and,/or Ca2*, making it a more readily cleavable substrate;
4. an increase of local prothrombin and factor X. concentra_
tion after binding to phospholipid and,/or factor Vu promoting
the formatioa of the prothrombin.prothrombinase complex]
5. binding of prothrombin, factor V", and factor X" to pt os-
pholipid in a favorable steric position. It is obvious thatihese
different mechanisms may act simultaneously. None of these
possibilities can be excluded on the basis of ihe properties of
the prothrombinase complex reported in the literature.
Knowledge of the effects of phospholipid and factor V" on
the kinetic parameters of prothrombin activation will be aprerequisite in order to elucidate their role in the mechanism
of the prothrombinase complex.
'The kinetic parameters of different prothrombin_activating
mixtures are summarized in Table I. tn the absence of acces_
sory components prothrombin is a very poor substrate for
factor X". The high K* value (131 prvri indicates that pro_
thromtrin has a low affinity for factor Xu under these co^ndi_
tions. Taking into account a plasma prothrombin concentra_
tion of about 1.5 prvr, which is far below the K*, and the low
V*,, of thrombin formation measured under these conditions,
it is unlikely that physiologrcally significant thrombin forma_
tion carr take place without involvement of phospholipid and
factor V,.
The small decrease of the K_ for prothrombin occurring
when the same experiment is carried out in the presence of
Oa'- may be the result of Ca2* binding to y_carboryglutamic
acid residues present in factor Xu and prothrombin. Since
K^ v^",
pM
2.6
4.0
5.3
7.5
8.0
1U.5
16.0
26.3
40.0
52.6
I D
80
105
240
mM
8
8
10
10
10
10
10
I D
15
25
25
25
32
40
pM + S.E.
0.032 + 0.003
0.062 i 0.005
0.054 + 0.003
0.058 t 0.005
0.09 + 0.02
0.068 + 0.008
0.14 r 0.01
0.164 + 0.006
0.23 + 0.02
0.25 + 0.01
0.35 + 0.03
0.46 I 0.01
0.48 + 0.05
1.08 + 0.07
mol II" min-' mol
&- ' rs . .g.
1.06 t 0.05
t.27 + 0.04
1.54 r 0.03
2.25 ! 0.05
2.04 + 0.20
1.75 + 0.09
2.35 + 0.08
2.71 + g.g4
3.12 + 6.16
2.90 r 0.07
3.90 + 0.10
3.52 I 0.03
3.31 + 0.20
4.10 + 0.10
" For each phospholipid concentration a Ca2*
formed to obtain the optimal Ca2* concentration.
titration was per-
o o.1 O2 ----- oF-
1 /  fphospho l ip id t  t  7U ' '  I
, 
Frc., 11_.. Double reciprocal plot of V_* as a function of thephospholipid concentration. The prothrombin activating mixture
consisted of factor X,, CaC_lz, and plospholipid. This ploicontainsdata summarized in Table II.
that the kinetic parameters measured in the experiments
described above are in fact those for a mixture of prothrombin
and its partial activation products liberated during the time
course of the reaction. However, gel electrophoretic analysis
of the products formed during prolhrombin'activation under
the conditions of our experiments shows that only a negligible
amount of prothrombin is converted into thrombin anl o"ther
glrtial activation products. preliminary experiments3 o" tfru
kinetics of prethrombin 1 and prethrombin 2 point out that apossible conversion of liberated activation pioducts cannot
contribute to thrombin formation in our experiments. To
investigate whether the changes of kinetic pLameters are
accompanied or caused by changes in thrj rbaclion pathway ofprothrombin activation it is necessary to devise experiments
in which sufficient activation products are formed. By increas_
ing the amount of enz5,'rne (factor X" and factor V", ii present)
" J. W. P. Govers-Riemslag and J. Rosing, unpublished observa-tions.
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Frc. 12. Time course of activation of prothrombin with dif-
ferent activating mixtures. A, prothrombin (13.4 ptu) was activated
with factor X. (1.82 prvr) in a buffer containing 100 mu NaCl, 25 mu
Tris, 2 mrl diisopropylphosphorofluoridate and 10 mrvr CaClz at 37"C
I N C U  B A T I O N  T  l M  E  ( m i  n ;
and pH 7.5. B, prothrombin (13.4 plvr) was activated with factor X"
(6.2 x 10-3 p.rvt) and factor V" (19 units/ml) in a buffer containing 100
mrrr NaCl, 25 mru Tris, 2 mu diisopropylphosphorofluoridate, and 3
mu CaCIz at 37"C and pH 7.5. Q prothrombin (2.68 p,tvt) was activated
o l
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Ca2* has no effect on the V* of thrombin formation we
conclude that the catalytic effrciency (k.^r/K*l of factor Xu is
virtually not changed upon Ca2* binding.
Important changes of kinetic parameters take place when
phospholipid or factor V,, or both, form part of the prothrom-
binase complex. Phospholipid causes a profound decrease of
the K- for prothrombin. In the presence of phospholipid the
K- decreases to values below 1 pu, which is lower than the
plasma prothrombin concentration.
The K- for prothrombin is, however, dependent on the
amount of phospholipid present (Table II). Higher K_ values
are measured at increasing phospholipid concentrations. The
.K- increases from 0.032 plvr at 2.6 prvr phospholipid to l.0g pu
at a phospholipid concentration of 240 pv.. Therefore, a K_
determined in the presence ofphospholipid has to be regarded
as an apparent K-. This is not surprising since the K_ value
is calculated using the concentrations of total added pro-
thrombin. However, the thrombin formed at the phospholipid
surface is in fact generated from bound prothrombin. The
prothrombin concentration at the K^ should, therefore, be
expressed in terms of surface concentration in those experi-
ments where K- values at different phospholipid concentra-
tions are compared. To calculate the amount of bound pro-
thrombin, binding parameters (e.g. available binding sites and
diss6sialion constants) have to be known for prothrombin
binding to the phospholipid vesicles under our experimental
conditions (temperature, pH, ionic strength, and [Car*]). Al-
though the appropriate binding data are not available, we
used as a first approximation prothrombin binding parameters
ofNelsestuen and Broderius (31). For conditions approaching
those of our experiments as close as possible (0.0b rvr Tds, 0.1
u NaCl, 5 mu CaClz at pH 7.5 and 25oC) they reported a
dissociation constant of 10-7u for the prothrombin.phos-
pholipid complex and 17 pmol of prothrombin binding sites
per g of phospholipid for vesicles prepared from a l/I (moI/
mol) mixture of bovine brain phosphatidylserine and egg yolk
phosphatidylcholine. Using these binding data we calculated
the prothrombin density at the phospholipid surface, ex-
pressed as micromoles of prothrombin bound per g of phos-
pholipid, at the K* measured at different phospholipid con-
centrations (Table III). Although the apparent K_ increases
when increasing amounts of phospholipid are present, the
prothrombin density at the phospholipid surface at the K_ is
independent of the phospholipid concentration. This means
that it is the local prothrombin concentration at the phospho-
lipid surface which determines the kinetics in this case. Our
experiments allow no conclusion as to what extent an in-
creased local prothrombin concentration explains the large
decrease ofthe K- observed in the presence ofphospholipid.
This implies also that the possibility that phospholipid brings
prothrombin and factor X" together in a more favorable
orientation, the so-called juxtaposing effect, cannot be evalu-
ated. Legitimate conclusions in this connection have to be
based on a theoretical treatment of enz5rme kinetics in solution
and heterogeneous enzJfine catalysis taking place at the phos-
pholipid surface. This requires, for instance, knowledge of
diffusion constants in solution and at the phospholipid surface,
Tanr,r III
K* for prothrombin and corresponding prothrombin density at the
phospholipi.d surface at uarying phospholipi.d concentrations
Phospholipid K^ Prothrombin densitv atphospholipid surface
pM
2.6
4.0
5.3
7.5
8.0
1U-5
16.0
26.3
40.0
52.6
l o
80
105
240
pM
0.032
0.062
0.054
0.058
0.090
0.068
0.14
0.164
0.23
o.25
0.35
0.46
0.48
1.08
pmol/g + S.E.
3.4 + 0.3
5.2 a 0.5
4.4 + 0.3
4.2 + 0.4
5.7 + 1.0
4.2 + 0.5
6.2 i 0.6
5.5 + 0.2
5.7 r 0.6
5.4 r 0.3
5.1 + 0.4
6.2 r 0.1
5.2 -f 0.5
5.4 * 0.4
appropriate binding data, and orientation at the phospholipid
surface of the proteins involved.
The role of factor V" in the complete prothrombinase com-
plex (factor X,, factor Vu, Ca2*, and phospholipid) is mainly
restricted to an effect on the V-"* of thrombin formation. A
700-fold increase of Y-^, is observed in the presence of factor
v".
With respect to the mode of action of factor V" in the
prothrombinase complex one has to consider whether factor
V" interacts with prothrombin, changing its properties as a
substrate or whether it forms a complex with factor X. with
a catalytic capacity different from free factor X.. We exclude
the possibility that factor V" exerts its stimulatory action,
independent of factor X" or prothrombin, by trapping poten-
tial inhibitory activation peptides released during prothrom-
bin activation. Neither fragment 1, fragment 2, nor fragment
1.2 inhibit thrombin formation at concentrations generated
during prothrombin activation in the time course of our ex-
periments. Since the factor V. concentration in our experi-
ments is always much lower than the prothrombin concentra-
tion a prothrombin.factor Vu complex, if present, will be a
small fraction of the total amount of prothrombin added. This
combined with the fact that a further increase of the amount
of factor Vu does not affect the kinetics of the reaction makes
it very unlikely that a prothrombin.factor Vu complex acts as
a substrate for factor Xu. Therefore, it seems plausible to
assume that a factor X..factor V. complex is the catalytic unit
in the prothrombinase complex.
In solution factor V. also exhibits a stimulating effect on
thrombin formation. However, from the experiment shown in
Fig. 5 it is clear that it is impossible to achieve complete
saturation of factor X" with factor Vu. At high concentrations
factor V. even inhibits thrombin formation. This phenome-
non, for which we have no explanation yet, prevents adding
saturating amounts of factor Vu. This leaves open the question
whether phospholipid actually has an additional effect on the
rate enhancement of thrombin formation brought about by
factor V,.
with factor )L (5.5 X 10-3 pru) in a buffer containing 100 mu NaCl, 25
aY f.i., 2 mrvr- 9iisopropylphosphorofluoridate, 75 prvr phospholipid,
and 25 mu CaClz at SZ.C and pH 7_.8. D, prothrom6in (Z.OS-pM) ias
activated with factor X, (6.2 x 10-5 pu) and factor V, (10 units/ml)
in a buffer containing 100 mna NaCl, 2b mrvr Tris, 2 mrvr diisopropyl_
phosphorofluoridate, 75 pnr phospholipid, and 5 mu CaClz it g7;C
and pH 7.5. In order to slow down prothrombin conversion by
thrombin formed 2 mrvr diisopropylphosphorofluoridate was includei
in the activation mixture. Time points at which samples were taken
and the identification of the band pattern are indicated in the figure.
Abbreviations used are: Pi, phospholipid; P?, prothrombin; F?1,
prethrombin I; X", factor X"; F1.2, fragment 1.2; ?, thrombin; pT2,
prethrombin 2; Tn, B chain of thrombin; X"11, heavy chain of factor
X,; and F1, fragment 1. For further experimental details see under
"Experimental Procedures." The last gel of each series (indicated by
ME) is a disulfide-reduced sample of the reaction mixture taken after
60 min of incubation. For this gel B-mercaptoethanol is used as
reducing agent.
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Comparison of the factor V. dependence of thrombin for-
mation in the absence and presence of phospholipid (Figs. 5
and 6) draws attention to another function of phospholipids
in the prothrombinase complex. Since much lower amounts
of factor Vu are required in the presence of phospholipid to
maximize the rate of thrombin formation, we conclude that
phospholipids promote the formation of the factor Vu'Xu
complex. This may be caused by increased local factor V. and
factor X" concentrations at the phospholipid surface afber
binding of both proteins to the vesicles. This will shift the
equilibrium of formation of the factor V.'X, complex in the
direction of association. For a discussion of the actual mech-
anism that causes the increased I/-** of thrombin formation
in the presence of factor V. it is helpful to consider Scheme 1,
depicting a minimal mechanism for the conversion of pro-
thrombin and other activation products.
The different proteins and complexes represented in this
scheme ate E, prothrombin activating complex; PT, pro-
thrombin; P?1, prethrombin 1; PT2,ptettvombin 2; ?, throm-
bin; Fl, prothrombin fragment 1; F2, prothrombin fragment
2; F1.2, prothrombin fragment 1.2.
The reactions represented in this scheme are based on
results reported in the literatur e (2-7 , 321 . Although thrombin
formation can take place with free prethrombin 1 or prethrom-
bin 2 as substrate (5), electrophoretic analysis shows that in
the course of our kinetic experiments such small amounts of
partial activation products accumulate that conversion of
intermediates released from the prothrombinase complex or
formed by the action of thrombin cannot contribute to the
amount of thrombin formed. Therefore, thrombin is generated
in our kinetic experiments via the pathway indicated by the
solid arrows (Steps 1, 2, 3, 4).
An intriguing explanation for the mechanism of rate en-
hancement by factor V. can be put forward on the basis ofthe
experiments (Fig. 12) in which the activation of prothrombin
with different prothrombin-activating mixtures is followed by
sodium dodecyl sulfate gel electrophoresis. The experimental
setup is a refinement of similar experiments carried out by
the group of Jackson (2, 4, 5,6). Our reaction conditions,
prothrombin concentration, and composition of activating
mixtures are chosen on the basis of knowledge obtained from
our kinetic experiments. When factor X. converts prothrom-
bin in the absence and presence of phospholipid, but in the
absence of factor V,, mainly prethrombin 2 is formed, while
with the complete prothrombinase complex (factor X., factor
V., phospholipid, and Ca'z*) thrombin is the main end product,
and no prethrombin 2 is detectable. Trace amounts of pre-
thrombin 2 are formed when factor X^ activates prothrombin
in the presence of factor V. and Ca2*. Since it is not possible
to saturate factor X" with factor V^ under these conditions
(Fig. 5) the small amounts of prethrombin 2 are likely formed
by free factor X.. Although such experiments are carried out
with larger amounts of factor X^ and for longer time periods,
it seems justified to correlate the implications of these findings
with those of the kinetic experiments. In that case we make
the following proposal for the mode of factor Vu action. The
main pathway occurring during prothrombin activation in the
1 2-  3 -  4
P r  +  E  *  p r . e  ?  n z . E  =  r . E  = E + r + F 1 . 2
F  1 . 2  F  1 . 2
+ l5 l l
t t
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Scnpun 1
absence of factor Vu, either in the absence or presence of
phospholipid, is that giving rise to prethrombin 2 formation
(steps 1, 2, 5). Only a small fraction of prothrombin is con-
verted into thrombin (Steps 1, 2,3,4) and is measured in the
kinetic experiments. Prethrombin 2 is the main end product
since it easily dissociates from factor X. (step 5). Reassociation
with factor X", which offers a second chance to be converted
to tbrombin, is inhibited by the large excess of prothrombin
present. Factor Vu changes the pathway of prothrombin acti-
vation from one resulting in prethrombin 2 (steps 1, 2, 5) into
one giving rise to thrombin (steps 1, 2, 3, 4l' Apparently the
presence of factor Vu prevents the dissociation of prethrombin
2 frorair the prothrombinase complex. The tight association
between fragment 1.2 and both prethrombin 2 and factor V"
(5) can explain why prethrombin 2 does not dissociate from
the prothrombinase complex. Dissociation of prethrombin 2
can, however, also be prevented when factor V" increases a
limiting rate constant'irccurring in the reaction scheme after
formation of the PT2.E complex. This will decrease the steady
state concentration of the latter intermediate, with a conse-
quent drop of the rate of dissociation of prethrombin 2. It
must be emphasized that more complex mechanisms may be
devised to accommodate our observations. However, the pro-
posed explanation for the observed shift in the pathway
brought about by factor V. is consistent with our results and
data available in the literature. A study on the kinetics of
activation of partial prothrombin activation products with
various activating mixtures and the effects of prothrombin
fragments thereon, in progress in our laboratory, will lead to
a more detailed description of the mechanism of prothrombin
activation.
Our findings may have important implications for the mech-
anism of other phospholipid.protein complexes that partici-
pate in blood coagulation. The role of factor VIII and phos-
pholipid in the factor X-activating complex consisting of factor
IX., factor VIII", phospholipid, and Ca'* and by extension, the
role of the protein and phospholipid component of tissue
thromboplastin in the extrinsic factor X activator (factor VII",
tissue thromboplastin, and Ca'*) may be identical with those
of phospholipid and factor V. in the prothrombinase complex.
Indeed Silverberg et al. (14\ reported that tissue factor in-
creases the A".t of factor X activation by factor VII" about
2900-fold and decreased the K- for factor X l0-fold. Since
tissue factor contains both the phospholipid and protein ac-
cessory component it is not possible to separate their effect
on the kinetic parameters. A kinetic study of the activation of
factor X by factor IX. in the absence and presence of factor
VIII", phospholipid, and Ca2* is in progress in our laboratory.
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